Glyscend Therapeutics Patents – Insights & Stats (Updated 2023)

Glyscend Therapeutics has a total of 38 patents globally, out of which 13 have been granted. Of these 38 patents, more than 89% patents are active. The United States of America is where Glyscend Therapeutics has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Glyscend Therapeutics.

Glyscend Therapeutics was founded in 2014. This company creates special medications using a type of material that targets the stomach. These drugs are made to treat conditions like type 2 diabetes and other ongoing health issues. The main product is a pill that you swallow, but it doesn’t get absorbed into the body. Instead, it stays in the stomach and works like a treatment that mimics the effects of weight loss surgery.

Do read about some of the most popular patents of Glyscend Therapeutics which have been covered by us in this article and also you can find Glyscend Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Glyscend Therapeutics patent portfolio.

How many patents does Glyscend Therapeutics have?

Glyscend Therapeutics has a total of 38 patents globally. These patents belong to 6 unique patent families. Out of 38 patents, 34 patents are active.

How Many Patents did Glyscend Therapeutics File Every Year?

Glyscend Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGlyscend Therapeutics Applications FiledGlyscend Therapeutics Patents Granted
202321
202243
202141
2020161
201952
201722
201511
201421
201211

How many Glyscend Therapeutics patents are Alive/Dead?

Worldwide Patents

Glyscend Therapeutics Patent Portfolio

How Many Patents did Glyscend Therapeutics File in Different Countries?

Glyscend Therapeutics Worldwide Patent Filing

Countries in which Glyscend Therapeutics Filed Patents

CountryPatent
United States Of America19
Japan3
Europe3
Australia1
Canada1
India1
Mexico1
China1
New Zealand1
Brazil1
Singapore1
Hong Kong (S.A.R.)1
Israel1

Where are Research Centers of Glyscend Therapeutics Patents Located?

The Research Centers of Glyscend Therapeutics Patents is the United States of America.

10 Best Glyscend Therapeutics Patents

US8142775B2 is the most popular patent in the Glyscend Therapeutics portfolio. It has received 10 citations so far from companies like Allena Pharmaceuticals, Ajinomoto Althea, Oxidien Pharmaceuticals.

Below is the list of 10 most cited patents of Glyscend Therapeutics:

Publication NumberCitation Count
US8142775B210
US8741284B28
US9155785B27
WO2020061430A17
US9821041B24
US9714456B24
WO2021055759A14
WO2021055752A14
US10369203B23
US10246755B22

What Percentage of Glyscend Therapeutics US Patent Applications Were Granted?

Glyscend Therapeutics (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100%.

Below are the key stats of Glyscend Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Glyscend Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Hogan Lovells Us Llp6100%

List of Glyscend Therapeutics patents

Glyscend Therapeutics PatentsTitle
US11576928B2Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
US11491182B2Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
US11491183B2Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
US11484548B2Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
US11208700B2Crystallized Oxalate Decarboxylase And Methods Of Use
US10570468B2Crystallized Oxalate Decarboxylase And Methods Of Use
US10369203B2Crystallized Oxalate Decarboxylase And Methods Of Use
US10246755B2Crystallized Oxalate Decarboxylase And Methods Of Use
US9821041B2Crystallized Oxalate Decarboxylase And Methods Of Use
US9714456B2Crystallized Oxalate Decarboxylase And Methods Of Use
US9155785B2Crystallized Oxalate Decarboxylase And Methods Of Use
US8741284B2Crystallized Oxalate Decarboxylase And Methods Of Use
US8142775B2Crystallized Oxalate Decarboxylase And Methods Of Use
US20230338415A1Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
US20220403361A1Crystallized Oxalate Decarboxylase And Methods Of Use
US20220396651A1Benzoxaborole Polymers And Methods Of Use
US20220378886A1Methods Of Treating Hyperoxaluria
US20210403625A1Boronic Acid Polymers And Methods Of Use
EP4031553A4Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
EP4041740A4Benzoxaborole Polymers And Methods Of Use
EP3852768A4Boronic Acid Polymers And Methods Of Use
CN114423768ASubstituted Phenylboronic Acid-Containing Polymers And Methods Of Use
JP2022548699A5Substituted Phenylboronic Acid-Containing Polymers And Methods Of Use
JP2022548698A5Benzoxaborol Polymers And Methods Of Use
JP2022501483A5Boronic Acid Polymers And Methods Of Use
HK40078118ASubstituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
IN202217020746ASubstituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
MX2022003384ASubstituted Phenyl Boronic Acid Containing Polymers And Methods Of Use.
BR112022004981A2Substituted Phenylboronic Acid Containing Polymers And Methods Of Use
IL291462ASubstituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
SG11202202168VASubstituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
AU2020348451A1Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
NZ786964ASubstituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
CA3150057A1Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
US20220133865A1Crystallized Oxalate Decarboxylase And Methods Of Use
WO2021055759A1Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use
WO2021055752A1Benzoxaborole Polymers And Methods Of Use
WO2020061430A1Boronic Acid Polymers And Methods Of Use

What are Glyscend Therapeutics key innovation segments?

What Technologies are Covered by Glyscend Therapeutics?

The chart below distributes patents filed by Glyscend Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Glyscend Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Glyscend Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Glyscend Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.